Q8 12H up to 72 hours Directions Burning stinging Rarely pupil dilation caution

Q8 12h up to 72 hours directions burning stinging

This preview shows page 10 - 15 out of 23 pages.

Q8-12H, up to 72 hours Directions •Burning, stinging •Rarely-pupil dilation, caution narrow angle glaucoma Safety Considerations OPHTHALMIC DECONGESTANTS Tetrahydrozoline, phenylephrine, oxymetazoline, naphazoline Mechanism of action Act on alpha-adrenergic receptors to cause vasoconstriction which reduces eye redness Tetrahydrozoline Naphazoline Oxymetazoline Phenylephrine OPHTHALMIC DECONGESTANTS • 1-2 drops, generally up to QID • Duration of 72 hours • Rebound congestion Directions •Possible pupil dilation •Caution in pregnancy •Systemic effects minimal, but warnings for: •Heart disease, HTN, difficult urination, diabetes, hyperthyroid, narrow angle glaucoma Safety considerations
Image of page 10
11/24/14 11 OPHTHALMIC ANTIHISTAMINES Pheniramine MOA H 1 -receptor antagonists Only combined with decongestants Pheniramine/naphazoline OPHTHALMIC ANTIHISTAMINES •1-2 drops, TID to QID, up to 72 hours Directions •Burning, stinging •Rarely-pupil dilation, caution narrow angle glaucoma Safety Considerations PRODUCT SELECTION Ketotifen Safest and most effective Convenient BID dosing Naphazoline, tetrahydrozoline Less rebound congestion Complementary therapies Similasan Eye Drops #2
Image of page 11
11/24/14 12 OTHER TYPES OF CONJUNCTIVITIS “PINK EYE” Viral •Highly contagious Colds, sore throat, exposure to virus •Clinical Presentation •Typically unilateral •Pink eye Watery discharge •Conjuctival swelling •Fever Bacterial •Highly contagious Exposure to bacteria •Clinical Presentation •Typically unilateral •Pink eye Purulent discharge •Conjuctival swelling •Fever TREATMENT OF VIRAL CONJUNCTIVITIS Nonpharmacologic therapy Cold compresses Good hygiene Avoid contact lenses, replace after infection clears Pharmacologic therapy Artificial tears Ophthalmic decongestants CORNEAL EDEMA Pathophysiology Ov erwear of contacts Surgical damage Corneal dystrophies Clinical Presentation Fluid accumulation distorts the optical properties resulting in halos or starbursts around lights Diagnosed by an eye care provider Treatment Topical ophthalmic hyperosmotic agents Solution or ointment
Image of page 12
11/24/14 13 CORNEAL EDEMA OPHTHALMIC HYPEROSMOTIC AGENTS NaCl hypertonicity solution or ointment Mechanism of action Increase the tonicity of the tear film promoting movement of the fluid from the cornea to the more highly osmotic tear film OPHTHALMIC HYPEROSMOTIC AGENTS •1-2 drops every 3-4 hours •Ointment typically QHS Directions •Contraindicated in corneal edema with damaged endothelium Safety considerations
Image of page 13
11/24/14 14 MINOR EYE IRRITATION Pathophysiology Foreign substance, contact lens wear, or exposure to irritants Clinical Presentation Immediate watering/tearing Redness of eye Pain or feeling of “sand in the eyes Treatment Artificial tears Ophthalmic ointment Ophthalmic irrigants OPHTHALMIC IRRIGANTS Mechanism of action
Image of page 14
Image of page 15

You've reached the end of your free preview.

Want to read all 23 pages?

  • Fall '14
  • Hussar
  • Ear canal, clinical presentation, •  Eye exposure, •  Eye pain

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture